Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib.
Valent
Jason N
JN
Schiffer
Charles A
CA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069439:Dasatinib; D006801:Humans; D016130:Immunophenotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008218:Lymphocytosis / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D015995:Prevalence; D011743:Pyrimidines / Q000627:therapeutic use*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013844:Thiazoles / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib